missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 18409792

CBR1 Antibody (2D6), DyLight 755, Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals NBP2-59397IR

Product Code. 18409792

  • € 569.00 / 0.10mL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

CBR1 Monoclonal antibody specifically detects CBR1 in Human samples. It is validated for Western Blot, Flow Cytometry, ELISA, Immunofluorescence
TRUSTED_SUSTAINABILITY
Specifications

Specifications

CBR1
Monoclonal
DyLight 755
15-hydroxyprostaglandin dehydrogenase [NADP+], carbonyl reductase (NADPH) 1, carbonyl reductase (NADPH) 1, EC 1.1.1.18410EC 1.1.1.197,15-hydroxyprostaglandin dehydrogenase, carbonyl reductase [NADPH] 1, carbonyl reductase 1, CBR, CRN, EC 1.1.1.184, EC 1.1.1.189, hCBR1, NADPH-dependent carbonyl reductase 1, Prostaglandin 9-ketoreductase, Prostaglandin-E(2) 9-reductase, SDR21C1, short chain dehydrogenase/reductase family 21C, member 1
Recombinant human CBR1 (1-277aa) purified from E. coli
0.1 mL
Stem Cell Markers
873
Store at 4°C in the dark.
IgG2a κ
Western Blot, Flow Cytometry, ELISA, Immunofluorescence
2D6
50mM Sodium Borate
Mouse
Protein A purified
RUO
Primary
Human
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.